Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pow-Sang

Showing results (221-230 of 264) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2016
Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine ProteomicsScott M Haake, Jiannong Li, Yun Bai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2018
Optimizing Time to Treatment to Achieve Durable Biochemical Disease Control after Surgery in Prostate Cancer: A Multi-Institutional Cohort StudyShivanshu Awasthi, Travis Gerke, Jong Y Park, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinomaMayer Fishman, Terri B Hunter, Hatem Soliman, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2024
Quantitative DCE Dynamics on Transformed MR Imaging Discriminates Clinically Significant Prostate CancerZhouping Wei, Malinda Iluppangama, Jin Qi, et al.
Clinical and Translational Radiation Oncology|October 22, 2025
Neoadjuvant prostate artery embolization prior to prostate radiation therapy: A single institution experience on the durability of clinical urinary improvement after radiationVaseem M Khatri, G Daniel Grass, Ram Thapa, et al.
Immunotherapy|April 20, 2012
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapySteven Eric Finkelstein, Francisco Rodriguez, Mary Dunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2023
A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the BladderRoger Li, Wade J Sexton, Jasreman Dhillon, et al.
Prostate Cancer and Prostatic Diseases|February 23, 2022
Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysisShivanshu Awasthi, Brandon A Mahal, Jong Y Park, et al.
Urologic Oncology|October 25, 2023
Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancerRoger Li, Shreyas Naidu, Wenyi Fan, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Prostate CancerR R Bahnson, G E Hanks, R P Huben, et al.
Pageof 27

Showing results (221-230 of 264) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2016
Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine ProteomicsScott M Haake, Jiannong Li, Yun Bai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2018
Optimizing Time to Treatment to Achieve Durable Biochemical Disease Control after Surgery in Prostate Cancer: A Multi-Institutional Cohort StudyShivanshu Awasthi, Travis Gerke, Jong Y Park, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinomaMayer Fishman, Terri B Hunter, Hatem Soliman, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2024
Quantitative DCE Dynamics on Transformed MR Imaging Discriminates Clinically Significant Prostate CancerZhouping Wei, Malinda Iluppangama, Jin Qi, et al.
Clinical and Translational Radiation Oncology|October 22, 2025
Neoadjuvant prostate artery embolization prior to prostate radiation therapy: A single institution experience on the durability of clinical urinary improvement after radiationVaseem M Khatri, G Daniel Grass, Ram Thapa, et al.
Immunotherapy|April 20, 2012
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapySteven Eric Finkelstein, Francisco Rodriguez, Mary Dunn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2023
A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the BladderRoger Li, Wade J Sexton, Jasreman Dhillon, et al.
Prostate Cancer and Prostatic Diseases|February 23, 2022
Substantial Gleason reclassification in Black men with national comprehensive cancer network low-risk prostate cancer - A propensity score analysisShivanshu Awasthi, Brandon A Mahal, Jong Y Park, et al.
Urologic Oncology|October 25, 2023
Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancerRoger Li, Shreyas Naidu, Wenyi Fan, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Prostate CancerR R Bahnson, G E Hanks, R P Huben, et al.
Pageof 27